INmune Bio: Some Promise, But Take Care Here
Seeking Alpha,
Summary INmune Bio is a unique immunotherapy company focusing on both neurobiology and cancer research.
Summary INmune Bio is a unique immunotherapy company focusing on both neurobiology and cancer research.
Summary Seven months separate BioVie investors from Phase 3 results in Alzheimer’s disease.
For nearly 30 years, the hunt for a cure for Alzheimer's disease has focused on a protein called beta-amyloid.
For nearly 30 years, the hunt for a cure for Alzheimer’s disease has focused on a protein called beta-amyloid.
Photo: Matt Artz. For nearly 30 years, the hunt for a cure for Alzheimer’s disease has focused on a protein called beta-amyloid.
Increasing evidence suggests that chronic inflammation takes a toll on the brain over the course of a lifetime For nearly 30…
The data highlights INmune Bios lead compound, XPro1595, as a potentially effective therapy to lower the risk for Alzheimers…
LA JOLLA, Calif., Jan. 02, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), an immunology company developing…
Dr. Malú Tansey's peer-reviewed data from INmune Bio's lead compound XPro1595 published in Alzheimer's Research
Dr. Malú Tansey's peer-reviewed data from INmune Bio's lead compound XPro1595 published in Alzheimer's Research
LA JOLLA, Calif., Jan. 02, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), an immunology company developing…
LA JOLLA, Calif., Jan. 02, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), an immunology company developing…
LA JOLLA, Calif., Jan. 02, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ:INMB), an immunology company developing treatments…
LA JOLLA, Calif., Jan. 02, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), an immunology company developing…
LA JOLLA, Calif., Jan. 02, 2020 (GLOBE NEWSWIRE) --. (NASDAQ: INMB), an immunology company developing treatments that harness…